{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:52:55Z","timestamp":1792518775330,"version":"4.5.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,6,3]]},"abstract":"\n Importance<\/jats:title>\n Electronic cigarette use (vaping) among adolescents and young adults is common. Few treatments have been tested in this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the efficacy of varenicline for nicotine vaping cessation in youth who do not smoke tobacco regularly.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A 3-group randomized clinical trial compared 12 weeks of double-blind varenicline vs placebo, each added to brief, remotely delivered behavioral counseling and compared with single-blind enhanced usual care, with monthly follow-up to 24 weeks. The trial was conducted among youth, aged 16 to 25 years, who vaped nicotine daily or near daily, did not regularly smoke tobacco, and wanted to reduce or quit vaping, in a single US state from June 2022 to May 2024. Data collection ended May 28, 2024.<\/jats:p>\n <\/jats:sec>\n \n Interventions<\/jats:title>\n Participants were randomized (1:1:1) to 12 weeks of varenicline titrated to 1 mg twice daily over 7 days (standard titration), weekly counseling, and referral to text messaging vaping cessation support (This is Quitting [TIQ]) (n\u2009=\u200988); identical placebo, weekly counseling, and referral to TIQ (n\u2009=\u200987); or enhanced usual care (referral to TIQ only) (n\u2009=\u200986).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Biochemically verified continuous vaping abstinence for the last 4 weeks of varenicline treatment vs placebo (primary outcome). Secondary outcomes included bioverified continuous abstinence from weeks 9 through 24 in the varenicline and placebo groups. Additional analyses compared varenicline group and placebo group with enhanced usual care.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of 261 randomized participants (mean age, 21.4 years; 53% female), 254 completed the trial (97.3%). For varenicline and placebo, continuous abstinence rates were 51% vs 14% during weeks 9 through 12 (adjusted odds ratio [aOR], 6.5 [95% CI, 3.0-14.1];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001) and 28% vs 7% during weeks 9 through 24 (aOR, 6.0 [95% CI, 2.1-16.9];\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Varenicline had higher continuous abstinence rates vs enhanced usual care during weeks 9 through 12 (51% vs 6%; aOR, 16.9 [95% CI, 6.2-46.3]) and during weeks 9 through 24 (28% vs 4%; aOR, 11.0 [95% CI, 3.1-38.8]). Continuous abstinence rates were not significantly different between the placebo and enhanced usual care groups. Study medication was generally well tolerated. Two varenicline participants (2%) and 1 placebo participant (1%) discontinued study medications due to adverse events. No drug-related serious adverse events occurred. Treatment-emergent adverse events were reported by 76 (86%) in the varenicline group, 68 (79%) in the placebo group, and 68 (79%) in the enhanced usual care group.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Varenicline, combined with behavioral counseling, increased vaping abstinence in youth who vape nicotine and do not regularly smoke tobacco.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT05367492<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jama.2025.3810","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T11:30:58Z","timestamp":1745407858000},"page":"1876","source":"Crossref","is-referenced-by-count":60,"title":["Varenicline for Youth Nicotine Vaping Cessation"],"prefix":"10.1001","volume":"333","author":[{"given":"A. Eden","family":"Evins","sequence":"first","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Cather","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison T.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Biostatistics Center, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryn","family":"Evohr","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Potter","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys N.","family":"Pachas","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Gray","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina, Charleston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Levy","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Addiction Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A.","family":"Rigotti","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Iroegbulem","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Dufour","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Casottana","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan A.","family":"Costello","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi M.","family":"Gilman","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi M.","family":"Schuster","sequence":"additional","affiliation":[{"name":"Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"44","key":"joi250016r1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.15585\/mmwr.mm7244a1","article-title":"Tobacco product use among US middle and high school students\u2014National Youth Tobacco Survey, 2023.","volume":"72","author":"Birdsey","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"35","key":"joi250016r3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.15585\/mmwr.mm7335a3","article-title":"Notes from the field: e-cigarette and nicotine pouch use among middle and high school students\u2014United States, 2024.","volume":"73","author":"Park-Lee","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"joi250016r4","doi-asserted-by":"publisher","first-page":"e2340859","DOI":"10.1001\/jamanetworkopen.2023.40859","article-title":"E-cigarette use among US adults in the 2021 Behavioral Risk Factor Surveillance System Survey.","volume":"6","author":"Erhabor","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"e1","key":"joi250016r5","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2020-056269","article-title":"Indicators of dependence and efforts to quit vaping and smoking among youth in Canada, England and the USA.","volume":"31","author":"Hammond","year":"2021","journal-title":"Tob Control"},{"issue":"3","key":"joi250016r6","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00976-2020","article-title":"Prospective association between use of electronic cigarettes and use of conventional cigarettes: a systematic review and meta-analysis.","volume":"7","author":"Adermark","year":"2021","journal-title":"ERJ Open Res"},{"issue":"10","key":"joi250016r7","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMsa1405092","article-title":"Shattuck Lecture: a molecular basis for nicotine as a gateway drug.","volume":"371","author":"Kandel","year":"2014","journal-title":"N Engl J Med"},{"key":"joi250016r8","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111402","article-title":"Longitudinal associations of e-cigarette use with cigarette, marijuana, and other drug use initiation among US adolescents and young adults: findings from the population assessment of tobacco and health study (waves 1-6).","volume":"263","author":"Evans-Polce","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"joi250016r9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.amepre.2023.12.005","article-title":"ENDS, cigarettes, and respiratory illness: longitudinal associations among US youth.","volume":"66","author":"Mukerjee","year":"2024","journal-title":"Am J Prev Med"},{"issue":"15","key":"joi250016r10","doi-asserted-by":"publisher","first-page":"9054","DOI":"10.3390\/ijerph19159054","article-title":"Health effects of electronic cigarettes: an umbrella review and methodological considerations.","volume":"19","author":"Travis","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"joi250016r11","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1136\/thoraxjnl-2015-208039","article-title":"Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner.","volume":"71","author":"Garcia-Arcos","year":"2016","journal-title":"Thorax"},{"issue":"9","key":"joi250016r12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/ntr\/ntae062","article-title":"Dual-vaping of nicotine and cannabis among adults who currently use tobacco products in five New England states.","volume":"26","author":"Liu","year":"2024","journal-title":"Nicotine Tob Res"},{"issue":"9","key":"joi250016r13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1001\/jama.2024.13403","article-title":"Vaping in youth.","volume":"332","author":"Winickoff","year":"2024","journal-title":"JAMA"},{"issue":"9","key":"joi250016r14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.2024.11057","article-title":"A vaping cessation text message program for adolescent e-cigarette users: a randomized clinical trial.","volume":"332","author":"Graham","year":"2024","journal-title":"JAMA"},{"key":"joi250016r15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1083791","article-title":"A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: study protocol.","volume":"14","author":"Schuster","year":"2023","journal-title":"Front Psychiatry"},{"issue":"2","key":"joi250016r16","doi-asserted-by":"publisher","first-page":"168","DOI":"10.15288\/jsa.1995.56.168","article-title":"Comparison of three alcohol consumption measures: a concurrent validity study.","volume":"56","author":"Grant","year":"1995","journal-title":"J Stud Alcohol"},{"issue":"2","key":"joi250016r17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/ntr\/ntu204","article-title":"Development of a questionnaire for assessing dependence on electronic cigarettes among a large sample of ex-smoking e-cigarette users.","volume":"17","author":"Foulds","year":"2015","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"joi250016r18","doi-asserted-by":"publisher","DOI":"10.2196\/25541","article-title":"Transitioning to remote clinic visits in a smoking cessation trial during the COVID-19 pandemic: mixed methods evaluation.","volume":"5","author":"Mahoney","year":"2021","journal-title":"JMIR Form Res"},{"issue":"3","key":"joi250016r20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal.","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"3-4","key":"joi250016r21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00213-005-0216-z","article-title":"Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.","volume":"184","author":"West","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"joi250016r22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/ntr\/nty046","article-title":"Development and validation of the questionnaire of vaping craving.","volume":"21","author":"Dowd","year":"2019","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"joi250016r23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.psychres.2009.03.005","article-title":"Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ).","volume":"179","author":"Wardenaar","year":"2010","journal-title":"Psychiatry Res"},{"issue":"3","key":"joi250016r24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.psychres.2013.12.018","article-title":"Validation of a short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ) in adolescents and young adults.","volume":"215","author":"Lin","year":"2014","journal-title":"Psychiatry Res"},{"issue":"6","key":"joi250016r25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s11606-019-04858-2","article-title":"Predictors of neuropsychiatric adverse events with smoking cessation medications in the randomized controlled EAGLES trial.","volume":"34","author":"Anthenelli","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"7","key":"joi250016r26","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/jamainternmed.2021.1793","article-title":"Effectiveness of a vaping cessation text message program among young adult e-cigarette users: a randomized clinical trial.","volume":"181","author":"Graham","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"joi250016r27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"2018","journal-title":"J R Stat Soc B"},{"issue":"4","key":"joi250016r28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1740774516634335","article-title":"Adherence adjustment in the Coronary Drug Project: a call for better per-protocol effect estimates in randomized trials.","volume":"13","author":"Murray","year":"2016","journal-title":"Clin Trials"},{"issue":"6","key":"joi250016r29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.5993\/AJHB.28.6.7","article-title":"Motivation and reasons to quit: predictive validity among adolescent smokers.","volume":"28","author":"Turner","year":"2004","journal-title":"Am J Health Behav"},{"issue":"1-2","key":"joi250016r30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugalcdep.2010.02.017","article-title":"An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R).","volume":"110","author":"Adamson","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"joi250016r31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption\u2013II.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"joi250016r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.106898","article-title":"A synthesis of the literature to inform vaping cessation interventions for young adults.","volume":"119","author":"Berg","year":"2021","journal-title":"Addict Behav"},{"issue":"3","key":"joi250016r33","doi-asserted-by":"publisher","first-page":"e234995","DOI":"10.1001\/jamanetworkopen.2023.4995","article-title":"Tobacco use, nicotine dependence, and cessation methods in US adults with psychosis.","volume":"6","author":"Han","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"4","key":"joi250016r34","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/add.14511","article-title":"Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States.","volume":"114","author":"Han","year":"2019","journal-title":"Addiction"},{"issue":"10037","key":"joi250016r35","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"joi250016r36","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1186\/s12889-023-16031-w","article-title":"Psychosocial stressors and current e-cigarette use in the youth risk behavior survey.","volume":"23","author":"Erhabor","year":"2023","journal-title":"BMC Public Health"},{"issue":"12","key":"joi250016r37","doi-asserted-by":"publisher","first-page":"e1916800","DOI":"10.1001\/jamanetworkopen.2019.16800","article-title":"Association between e-cigarette use and depression in the Behavioral Risk Factor Surveillance System, 2016-2017.","volume":"2","author":"Obisesan","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"joi250016r38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamapediatrics.2023.6263","article-title":"Substance use, suicidal thoughts, and psychiatric comorbidities among high school students.","volume":"178","author":"Tervo-Clemmens","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"11","key":"joi250016r39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S2352-4642(20)30243-1","article-title":"High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trial.","volume":"4","author":"Gray","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"12","key":"joi250016r40","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jamapediatrics.2019.3553","article-title":"Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial.","volume":"173","author":"Gray","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"1","key":"joi250016r41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jsat.2010.08.010","article-title":"Bupropion SR and contingency management for adolescent smoking cessation.","volume":"40","author":"Gray","year":"2011","journal-title":"J Subst Abuse Treat"},{"issue":"24","key":"joi250016r42","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijerph17249592","article-title":"Intervention fatigue is the primary cause of strong secondary waves in the COVID-19 pandemic.","volume":"17","author":"Rypdal","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"joi250016r2","unstructured":"Center for Behavioral Health Statistics and Quality. Table 2.1B\u2014tobacco product use, nicotine vaping, and alcohol use in lifetime, past year, and past month: among people aged 12 or older; by age group, percentages, 2022 and 2023. Substance Abuse and Mental Health Services Administration. Published 2024. Accessed March 11, 2025. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt47100\/NSDUHDetailedTabs2023\/NSDUHDetailedTabs2023\/2023-nsduh-detailed-tables-sect2pe.htm"},{"key":"joi250016r19","unstructured":"iScreen Oral Fluid Test Drug Screen Pad. Abbott. Accessed November 11, 2024. https:\/\/www.toxicology.abbott\/us\/en\/products\/iScreen-oral-fluid-test-drug-screen-pad.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2833137\/jama_evins_2025_oi_250016_1788358550.7459.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:00:41Z","timestamp":1789052441000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2833137"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":42,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2025,6,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.3810","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}